Clarification sought from IOL Chemicals & Pharmaceuticals Ltd
The Exchange has sought clarification from IOL Chemicals & Pharmaceuticals Ltd on October 24, 2017, with reference to increase in Price.The reply is awaited.24-10-2017
24-10-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for indiaSTAR (Mauritius) Ltd21-10-2017
Shareholding for the Period Ended September 30, 2017
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here20-10-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for indiaSTAR (Mauritius) Ltd19-10-2017
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements)Regulations, 2015
Dear Sir, Please find attached herewith Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 201511-10-2017
Half Yearly Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations. 2015
Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclose herewith compliance certificate for the half year ended 30 September 2017. Hope you will find the same in order.10-10-2017
Intimation Under Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Statement Of Investor Complaints For The Quarter Ended 30 September 2017
Pursuant to Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below Statement of Investor Complaints of the Company for the quarter ended 30 September 2017: Particulars Quarter ended 30 September 2017...10-10-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for indiaSTAR (Mauritius) Ltd06-10-2017
Alcon to introduce Clareon, an intraocular lens with advanced optic material
Alcon, the global leader in eye care and a division of Novartis, will introduce Clareon, the intraocular lens (IOL) with the most advanced optic material available in an automated, disposable, preloaded delivery system,04-10-2017
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here29-09-2017